Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

FDA Approval: Alectinib for the Treatment of Metastatic, ALK-Positive Non-Small Cell Lung Cancer Following Crizotinib.

Larkins E, Blumenthal GM, Chen H, He K, Agarwal R, Gieser G, Stephens O, Zahalka E, Ringgold K, Helms W, Shord S, Yu J, Zhao H, Davis G, McKee AE, Keegan P, Pazdur R.

Clin Cancer Res. 2016 Nov 1;22(21):5171-5176. Epub 2016 Jul 13.

2.

U.S. Food and Drug Administration Approval: Cabozantinib for the Treatment of Advanced Renal Cell Carcinoma.

Singh H, Brave M, Beaver JA, Cheng J, Tang S, Zahalka E, Palmby TR, Venugopal R, Song P, Liu Q, Liu C, Yu J, Chen XH, Wang X, Wang Y, Kluetz PG, Daniels SR, Papadopoulos EJ, Sridhara R, McKee AE, Ibrahim A, Kim G, Pazdur R.

Clin Cancer Res. 2017 Jan 15;23(2):330-335. doi: 10.1158/1078-0432.CCR-16-1073. Epub 2016 Oct 28.

3.

Historical control data of spontaneous tumors in transgenic CByB6F1-Tg(HRAS)2Jic (Tg.rasH2) mice.

Paranjpe MG, Elbekaei RH, Shah SA, Hickman M, Wenk ML, Zahalka EA.

Int J Toxicol. 2013 Jan-Feb;32(1):48-57. doi: 10.1177/1091581812471565. Epub 2013 Jan 16.

PMID:
23324159
4.

Reduction in the number of animals and the evaluation period for the positive control group in Tg.rasH2 short-term carcinogenicity studies.

Shah SA, Paranjpe MG, Atkins PI, Zahalka EA.

Int J Toxicol. 2012 Sep-Oct;31(5):423-9. doi: 10.1177/1091581812458957. Epub 2012 Sep 17.

PMID:
22988008
5.

Effects of food restriction on testis and accessory sex glands in maturing rats.

Rehm S, White TE, Zahalka EA, Stanislaus DJ, Boyce RW, Wier PJ.

Toxicol Pathol. 2008 Jul;36(5):687-94. doi: 10.1177/0192623308320275. Epub 2008 Jul 22.

PMID:
18648097
6.
7.

Alterations in hippocampal hemicholinium-3 binding and related behavioural and biochemical changes after prenatal phenobarbitone exposure.

Zahalka EH, Rehavi M, Newman ME, Yanai J.

Psychopharmacology (Berl). 1995 Nov;122(1):44-50.

PMID:
8711063
8.

Reversal of early phenobarbital-induced cholinergic and related behavioral deficits by neuronal grafting.

Rogel-Fuchs Y, Zahalka EA, Yanai J.

Brain Res Bull. 1994;33(3):273-9.

PMID:
8293312
9.

Dexamethasone treatment in utero enhances neonatal cholinergic nerve terminal development in rat brain.

Zahalka EA, Seidler FJ, Slotkin TA.

Res Commun Chem Pathol Pharmacol. 1993 Aug;81(2):191-8.

PMID:
8210698
10.

Fetal nicotine exposure alters ontogeny of M1-receptors and their link to G-proteins.

Zahalka EA, Seidler FJ, Yanai J, Slotkin TA.

Neurotoxicol Teratol. 1993 Mar-Apr;15(2):107-15.

PMID:
8510605
11.

Septohippocampal cholinergic changes after destruction of the A10-septal dopaminergic pathways.

Yanai J, Rogel-Fuchs Y, Pick CG, Slotkin T, Seidler FJ, Zahalka EA, Newman ME.

Neuropharmacology. 1993 Feb;32(2):113-7.

PMID:
8450940
12.
13.
14.

Alterations in septohippocampal cholinergic innervations and related behaviors after early exposure to heroin and phencyclidine.

Yanai J, Avraham Y, Levy S, Maslaton J, Pick CG, Rogel-Fuchs Y, Zahalka EA.

Brain Res Dev Brain Res. 1992 Oct 23;69(2):207-14.

PMID:
1424097
15.

Alterations in hippocampal cholinergic receptors and hippocampal behaviors after early exposure to nicotine.

Yanai J, Pick CG, Rogel-Fuchs Y, Zahalka EA.

Brain Res Bull. 1992 Sep-Oct;29(3-4):363-8.

PMID:
1393609
16.

Hippocampal cholinergic alterations and related behavioral deficits after early exposure to phenobarbital.

Rogel-Fuchs Y, Newman ME, Trombka D, Zahalka EA, Yanai J.

Brain Res Bull. 1992 Jul;29(1):1-6.

PMID:
1504846

Supplemental Content

Loading ...
Support Center